Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Pharmacol ; 75(6): 1325-36, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19297521

ABSTRACT

Design of dual antagonists for the chemokine receptors CCR2 and CCR5 will be greatly facilitated by knowledge of the structural differences of their binding sites. Thus, we computationally predicted the binding site of the dual CCR2/CCR5 antagonist N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzohepten-8-yl] carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium (TAK-779), and a CCR2-specific antagonist N-(carbamoylmethyl)-3-trifluoromethyl benzamido-parachlorobenzyl 3-aminopyrrolidine (Teijin compound 1) in an ensemble of predicted structures of human CCR2 and CCR5. Based on our predictions of the protein-ligand interactions, we examined the activity of the antagonists for cells expressing thirteen mutants of CCR2 and five mutants of CCR5. The results show that residues Trp98(2.60) and Thr292(7.40) contribute significantly to the efficacy of both TAK-779 and Teijin compound 1, whereas His121(3.33) and Ile263(6.55) contribute significantly only to the antagonistic effect of Teijin compound 1 at CCR2. Mutation of residues Trp86(2.60) and Tyr108(3.32) adversely affected the efficacy of TAK-779 in antagonizing CCR5-mediated chemotaxis. Y49A(1.39) and E291A(7.39) mutants of CCR2 showed a complete loss of CCL2 binding and chemotaxis, despite robust cell surface expression, suggesting that these residues are critical in maintaining the correct receptor architecture. Modeling studies support the hypothesis that the residues Tyr49(1.39), Trp98(2.60), Tyr120(3.32), and Glu291(7.39) of CCR2 form a tight network of aromatic cluster and polar contacts between transmembrane helices 1, 2, 3, and 7.


Subject(s)
Amides/chemistry , Benzamides/chemistry , CCR5 Receptor Antagonists , Pyrrolidines/chemistry , Quaternary Ammonium Compounds/chemistry , Receptors, CCR2/antagonists & inhibitors , Receptors, CCR2/chemistry , Receptors, CCR5/chemistry , Amides/pharmacology , Animals , Benzamides/pharmacology , Binding Sites , Binding, Competitive , Cell Line, Tumor , Chemotaxis , Humans , Mice , Models, Molecular , Point Mutation , Protein Conformation , Pyrrolidines/pharmacology , Quaternary Ammonium Compounds/pharmacology , Radioligand Assay , Receptors, CCR2/genetics , Receptors, CCR5/genetics
2.
Bioorg Med Chem Lett ; 18(14): 3891-4, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18586492

ABSTRACT

The synthesis and biological evaluation of a series of N-alkyl glycine amide analogs as LTA(4)-h inhibitors and the importance of the introduction of a benzoic acid group to the potency and pharmacokinetic parameters of our analogs are described. The lead compound in the series, 4q, has excellent potency and oral bioavailability.


Subject(s)
Amides/chemistry , Enzyme Inhibitors/pharmacokinetics , Epoxide Hydrolases/antagonists & inhibitors , Glycine/chemistry , Administration, Oral , Amines/chemistry , Anti-Inflammatory Agents/pharmacology , Benzoic Acid/chemistry , Biological Availability , Chemistry, Pharmaceutical , Drug Design , Ethers , Inhibitory Concentration 50 , Models, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...